Wainer Andrea F's Form 4 filing
Abbott Laboratories (ABT) · filed Aug 10, 2023
- Accession no.
- 0001415889-23-012074
- Filed
- Aug 10, 2023
- Trade date
- Aug 8, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.09M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wainer Andrea FCIK 0001778070 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | Common shares without par value | MOption exerciseAcquired | +5,000 | $38.40 | +$192,000 | 75,427 | Direct | |
| Aug 8, 2023 | Common shares without par value | SSaleDisposed | −4,741 | $105.00 | −$497,805 | 70,686 | Direct | |
| Aug 8, 2023 | Common shares without par value | SSaleDisposed | −244 | $105.43 | −$25,724.92 | 70,442 | Direct | |
| Aug 8, 2023 | Common shares without par value | SSaleDisposed | −15 | $107.42 | −$1,611.3 | 70,427 | Direct | |
| Aug 8, 2023 | Common shares without par value | SSaleDisposed | −5,112 | $105.00 | −$536,760 | 65,315 | Direct | |
| Aug 8, 2023 | Common shares without par value | SSaleDisposed | −272 | $105.43 | −$28,676.96 | 65,043 | Direct | |
| Aug 8, 2023 | Common shares without par value | SSaleDisposed | −16 | $107.42 | −$1,718.72 | 65,027 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | Common Shares | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.